OSHA Urges Workplaces to Stock Overdose Reversal Medication and Train Workers

On September 24, 2026, the U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) released new guidance urging employers to prepare for a workplace opioid overdose by stocking FDA-approved reversal medications and training workers to recognize the warning signs. The fact sheet, titled “Opioid Overdose Rescue with Reversal Medications,” treats an overdose the way many workplaces already treat cardiac arrest or severe bleeding: as a survivable emergency when the right tools and trained people are on hand. It is guidance, not a new rule, but it puts a clear, practical playbook in front of every American employer.

What OSHA announced

OSHA published the guidance as part of a broader federal recovery effort, framed by the agency under what it called the “Great American Recovery Initiative.” The centerpiece is straightforward advice: keep opioid reversal medication accessible in the workplace, teach employees how to spot an overdose, and make sure someone can act in the minutes before paramedics arrive. The agency points employers to two FDA-approved options, naloxone and nalmefene, and notes that these medications “quickly restore normal breathing and generally have no effect if opioids are not present” — an important point, because it means a bystander who is unsure can act without fear of harming a person who is not actually overdosing.

Acting Secretary of Labor Keith Sonderling said the guidance “is exactly the kind of action we were tasked with delivering.” White House Drug Czar Sara Carter added that “it is critically important that the American workforce is familiar with drug overdose recognition and reversal.” The document itself is a short, plain-language fact sheet (OSHA publication 4519) rather than a regulation, and OSHA has been explicit that it “does not create new compliance requirements.” In other words, no employer is being cited for failing to stock naloxone today. The point is readiness.

Why a workplace opioid overdose is a real safety issue

Overdoses are not an abstract risk for American workplaces. According to the Bureau of Labor Statistics’ Census of Fatal Occupational Injuries, unintentional overdoses from nonmedical use of drugs or alcohol caused 512 fatal work injuries in 2023 and 410 in 2024. That decline is encouraging, but the figure still represents hundreds of workers who died on the job from an overdose in a single year — deaths that, in many cases, could have been interrupted if a coworker had reversal medication within reach and knew how to use it.

The math of an opioid overdose is a math of minutes. Opioids suppress the drive to breathe, and brain damage or death can follow within a short window once breathing slows or stops. Emergency medical services are essential, but even a fast ambulance rarely arrives in the first few minutes. That gap is exactly where a trained coworker and an accessible dose of naloxone or nalmefene can make the difference between a fatality and a recovery. For safety professionals, this is the same logic that made automated external defibrillators (AEDs) standard equipment — you place the lifesaving tool where the emergency is likely to happen, before it happens.

What you should do

OSHA’s guidance boils down to a handful of concrete steps any employer or safety manager can take. Recognizing an overdose quickly is the first and most important skill, so start there.

• Know the signs: slow or stopped breathing, blue or gray lips or skin, pinpoint pupils, and unresponsiveness are the classic indicators of an opioid overdose.
• Stock reversal medication: keep FDA-approved naloxone or nalmefene on site, placed in visible, accessible locations alongside first-aid kits or AEDs.
• Train your people: make sure workers know where the medication is and how to administer whichever form your workplace stocks, whether nasal spray or injectable.
• Call 911 every time: administer the medication and call emergency services immediately, even if the person wakes up, because the reversal can wear off and a second overdose can follow.
• Maintain the supply: check expiration dates on a schedule and follow the manufacturer’s storage instructions so a dose actually works when it is needed.

What to do if you suspect an overdose. Call 911 first or have someone call, then give naloxone or nalmefene if it is available, and stay with the person. If breathing does not return, be ready to give additional doses per the product instructions and start rescue breathing or CPR if you are trained. Do not leave the person alone, even after they respond — the medication is temporary and professional care is still essential.

---

Where reversal medication fits alongside your PPE and first-aid program

For workplaces that already run a mature safety program, adding overdose readiness is a small step rather than a new burden. Naloxone kits are inexpensive, shelf-stable within their labeled limits, and simple to use — the nasal-spray form requires no needles and no medical training to administer. Many organizations are folding overdose response into their existing first-aid and CPR/AED training so responders learn one integrated emergency workflow instead of several disconnected ones. Some states and localities also run programs that provide naloxone to employers at reduced or no cost, and pharmacies across the country dispense it without an individual prescription, which makes stocking a kit easier than it once was.

It is worth being clear-eyed about scope. This is a hazard that can appear in any industry and any building, not just in high-risk trades, because it can involve a member of the public, a visitor, or a coworker. Treating readiness as a general workplace-safety measure — the way you treat a fire extinguisher or an eyewash station — keeps the focus on saving a life rather than on assumptions about who might be affected.

Context and what is next

Because the fact sheet is guidance rather than a standard, employers are not required to act on it, and OSHA cannot cite a workplace solely for lacking reversal medication. Still, guidance from OSHA often signals where the agency’s attention is heading and shapes what inspectors and industry groups treat as best practice. Employers who build overdose response into their emergency plans now are aligning with a clear federal recommendation and, more importantly, giving their workers a real chance to survive an event that unfolds in minutes. For safety leaders, the practical next step is simple: review your emergency action plan, decide where reversal medication belongs in your facility, and add recognition and response to your next training cycle. The full fact sheet is available directly from OSHA for anyone who wants to build a program around it.

Disclaimer. This article is for general safety information only and is not medical or legal advice. It summarizes federal guidance as of its publication date; guidance and requirements can change. Always follow the instructions that come with any medication, your employer’s emergency action plan, and the direction of emergency medical professionals. In an emergency, call 911.

Sources: OSHA news release, Sept. 24, 2026; OSHA fact sheet: Opioid Overdose Rescue with Reversal Medications (OSHA 4519); U.S. Bureau of Labor Statistics, Census of Fatal Occupational Injuries (Table 2).